Skip to content
The Longevity Archive
Lorecivivint in all countries

Legal status · United States

Is Lorecivivint legal in the United States?

InvestigationalHealing & RecoveryEvidence: Moderate

No. Lorecivivint is not approved for any medical use in the United States; its classification is "Investigational, not approved". Lawful access is limited to registered clinical trials. "Research use only" labeling on vials sold online does not make human use lawful. Human evidence to date: Moderate.

Lorecivivint in the United States at a glance

ClassificationInvestigational, not approved
FDA approval statusNDA under FDA review (submitted January 2026)
Evidence levelModerate (research strength: Strong)
ReviewedSep 2026

Classification and note come from the Lorecivivint profile, checked against U.S. Food and Drug Administration (FDA) listings at the reviewed date.

What this means

  • 01

    Lorecivivint is being studied in registered clinical trials but has not received FDA marketing approval in the United States.

  • 02

    Lawful human access is limited to trial participation or a formal early-access scheme where one exists; there is no pharmacy product to prescribe.

  • 03

    Vials sold online "for research use only" are not trial material, and that label does not make human use lawful.

What Lorecivivint is

An injected Wnt-pathway small molecule for knee osteoarthritis, given once or twice a year, with an NDA submitted to the FDA in January 2026 after multi-year cartilage-preservation data.

Lorecivivint inhibits CLK and DYRK1A kinases to modulate Wnt signaling in the joint, aiming to slow cartilage loss rather than only relieve pain. After a mixed Phase 3 history, Biosplice's long-term OA-07 data showed preservation of joint-space width over several years, and the company submitted a New Drug Application on January 6, 2026.

Mechanism: Intra-articular CLK/DYRK1A inhibition that modulates Wnt signaling, reducing inflammation and promoting chondrocyte health.

Regulatory history: NDA under FDA review (submitted January 2026)

How FDA treats this kind of product

Approves prescription drugs by indication and polices unapproved products, including peptides sold online. Compounding pharmacies may prepare some compounds under a prescription when the FDA places them on a permitted bulk-substances category.

The classification above is the The Longevity Archive reading of U.S. Food and Drug Administration listings for Lorecivivint at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.

Lorecivivint in other countries

Frequently asked questions

Is Lorecivivint legal in the United States?

No. Lorecivivint is not approved for any medical use in the United States; its classification is "Investigational, not approved". Lawful access is limited to registered clinical trials. "Research use only" labeling on vials sold online does not make human use lawful. Human evidence to date: Moderate.

Can I buy Lorecivivint in the United States?

No approved product exists to buy. In the United States Lorecivivint is classified as "Investigational, not approved", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors.

Is Lorecivivint FDA approved?

No. FDA status: NDA under FDA review (submitted January 2026). Current US classification: "Investigational, not approved". Evidence level: Moderate.

Related compounds in the United States

Full research profile

Mechanism, cited studies, FDA status and the full legal summary for Lorecivivint live on its compound profile.

Lorecivivint profile

This page is general information about the regulatory status of Lorecivivint in the United States, current as of Sep 2026. It is not legal advice, and classifications change; check U.S. Food and Drug Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.